Nalaganje...

Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer

Malignant pleural effusion (MPE) is a common complication of lung cancer with devastating consequences. Since vascular endothelial growth factor (VEGF) has been implicated in MPE, we hypothesized that bevacizumab, an anti-VEGF antibody, may be effective against MPE in patients with non-small-cell lu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Clin Oncol
Main Authors: MASAGO, KATSUHIRO, FUJIMOTO, DAICHI, FUJITA, SHIRO, HATA, AKITO, KAJI, REIKO, OHTSUKA, KYOKO, OKUDA, CHIYUKI, TAKESHITA, JUMPEI, KATAKAMI, NOBUYUKI
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360875/
https://ncbi.nlm.nih.gov/pubmed/25798278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.457
Oznake: Označite
Brez oznak, prvi označite!